Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Kabushiki Kaisha Shofu is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are assigned to 2 distinct examiners, ensuring that each matter is reviewed by a different individual. This spread across 2 distinct examiners suggests that the company is receiving multiple perspectives on its pharmaceutical claims. Both pending actions are situated within 1 distinct art unit, which implies a focused technical area for these specific filings.
KUVAYSKAYA, ANASTASIA ALEKSEYEVNA is the busiest examiner for this entity, currently holding 1 pending office action. This accounts for one of the 2 pending office actions in the portfolio. With 2 distinct examiners working within 1 distinct art unit, the company can compare how different examiners interpret the same set of art unit standards. Practitioners should use the insights gained from both of the 2 pending office actions to refine their overall prosecution strategy in this technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUVAYSKAYA, ANASTASIA ALEKSEYEVNA | 1 | 72.3% | +36.1% |
| AZUBUOGU, CHIEMERIE CHIBUZOR | 1 | 0.0% | +0.0% |
| ROBERTS, LEZAH | 1 | 48.4% | +35.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266086 | POWDER MIXTURE FOR SPRAYING INTO TOOTH SURFACE OR INTO GINGIVAL SULCUS/PERIODONTAL POCKET | ROBERTS, LEZAH | 14d |
| 18613598 | DENTAL POLISHING INSTRUMENT | KUVAYSKAYA, ANASTASIA ALEKSEYEVNA | — |
| 18609169 | DENTAL POLISHING INSTRUMENT | AZUBUOGU, CHIEMERIE CHIBUZOR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266086 | POWDER MIXTURE FOR SPRAYING INTO TOOTH SURFACE OR INTO GINGIVAL SULCUS/PERIODONTAL POCKET | ROBERTS, LEZAH | 14d |
| 18613598 | DENTAL POLISHING INSTRUMENT | KUVAYSKAYA, ANASTASIA ALEKSEYEVNA | — |
| Art Unit | Apps |
|---|---|
| 3772 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18613598 | DENTAL POLISHING INSTRUMENT | KUVAYSKAYA, ANASTASIA ALEKSEYEVNA | — | §102§103§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18609169 | DENTAL POLISHING INSTRUMENT | AZUBUOGU, CHIEMERIE CHIBUZOR | 3772 | §103 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18266086 | POWDER MIXTURE FOR SPRAYING INTO TOOTH SURFACE OR INTO GINGIVAL SULCUS/PERIODONTAL POCKET | ROBERTS, LEZAH | 1612 | §103§112 | Non-Final OA | 14d | Pending | Jun 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial